Overexpressing CD95 in GIC did not enhance clonogenic growth, suggesting that CD95L-independent tumor-promoting CD95 signaling may sustain constitutive cancer cell growth, but does not do so in a simple linear dose-dependent manner (Fig. S8). Here, FASLG is linked to cancer.